|TTH -- Canada Stock|| |
CAD 1.93 0.00 0.00%
Dr. Aleksandra Pastrak is Vice President Clinical Development and Medical Officer of Transition Therapeutics Inc. Dr. Pastrak was with Transition since 1999 and served as VP Research since 2005 until she was appointed VP Clinical Development in 2011. With her expertise in medicine and pharmacology she has made an invaluable contribution to the development of our clinical programs for various therapeutic products
Age: 45 VP Since 2011 Ph.D
Pastrak holds an MD from the School of Medicine at the University of Belgrade and M.Sc. and Ph.D. degrees in Clinical Pharmacology from the University of Toronto.